Insider Transactions in Q2 2023 at Lumos Pharma, Inc. (LUMO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 04
2023
|
John C. Mc Kew Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,214
-8.71%
|
$6,642
$3.27 P/Share
|
|
Apr 01
2023
|
Richard J Hawkins Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,522
-0.2%
|
$4,566
$3.31 P/Share
|
|
Apr 01
2023
|
Lori D Lawley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-2.38%
|
$822
$3.31 P/Share
|
|
Apr 01
2023
|
John C. Mc Kew Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,036
-3.92%
|
$3,108
$3.31 P/Share
|
|
Apr 01
2023
|
Bradley J Powers General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-5.4%
|
$1,026
$3.31 P/Share
|